Predictors of immunotherapy induced immune-related adverse events Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
CPAP can decrease fatal and non-fatal cardiovascular events in OSAH Source: ISSN=ISSN 1810-6838, ISBN=, page=266 Year: 2006
Neutrophils and the increased risk of cardiovascular events in severe COPD Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012
Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020
The influencing of respiratory adverse effects of enalapril Source: Eur Respir J 2001; 18: Suppl. 33, 264s Year: 2001
Can CPAP reduce adverse cardiovascular and metabolic effects of OSAS? Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007
Adverse events and mortality in the INSPIRE study (investigating new standards for prophylaxis in reduction of exacerbations) Source: Eur Respir J 2007; 30: Suppl. 51, 125s Year: 2007
Exercise: management of adverse events: discussion of clinical cases Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012
Polymorphisms in genes associated with the development of steroids-induced adverse events Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012
Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
The effects of climate changes and extreme events on respiratory allergy Source: International Congress 2014 – ERS/World Allergy Organisation "Climate change, air pollution and respiratory diseases" Year: 2014
Late Breaking Abstract - Low lung function, sudden cardiac death and non-fatal coronary events in the general population Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021
Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Asthma exacerbations during pregnancy increase risk of adverse perinatal outcomes Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020
Predicting adverse events from pulmonary embolism (PE): does the wicki score identify patients suitable for early discharge? Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003
Community acquired pneumonia: an increased risk for subsequent cardiovascular events? Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020
Management of disease- and therapy-related adverse events Source: ERS Online Course 2019: Essentials of modern lung cancer care – catch up with the latest advances Year: 2019
Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2012; 39: 906-912 Year: 2012
Severe adverse reactions in asthmatic children treated with specific immunotherapy(s.I.T.) Source: Eur Respir J 2003; 22: Suppl. 45, 318s Year: 2003
Correlation of response to antifibrotic treatment with adverse events to antifibrotic drugs in IPF patients from the real-world EMPIRE registry Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020